Skip to main content
. 2021 May 7;9(4):451–460. doi: 10.1002/ueg2.12069

TABLE 2.

Factors associated with increased fecal calprotectin concentration

Gastrointestinal diseases Range of FC increase (µg/g)
Colorectal neoplasia 70 57–133
Colon polyps 68 1–117.7
Colonic diverticular disease 69 <15–60
Bacterial and viral gastrointestinal infections 72 0–994
Gastrointestinal bleeding 71 <20–429
Liver cirrhosis 73 21–357
Irritable bowel syndrome 67 16–294
Microscopic colitis 74 130–480
Proctitis after radiation therapy 75 50–270
Pouchitis 76 55–110
Medication
Non‐steroidal anti‐inflammatory drugs 82 5–520
Proton pump inhibitors 79 50–150
Lifestyle
Obesity 90 5–185
Physical inactivity 87 25–60
Other
Age < 9 years 85 18–213
Age > 65 years 85 14–118
Bowel preparation for colonoscopy 84 51–17,379
Rheumatologic diseases 77 14–513
Perianal disease 91 207–1705
Stoma 88 <150–1130

Abbreviation: FC, fecal calprotectin.